GYPA and sarcoma: Notably, a group developing a modified, sarcoma-specific GPA index determined that the number of CNS metastases (1, 2–4, or more than 4) significantly affected the median overall survival, where the smaller number of lesions indicated a better prognosis (Patrikidou et al. 2020).